Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Kemnade JO, Florez M, Sabichi A, Zhang J, et al. Oral Oncol 2023;145:106536.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kemnade JO, Florez M, Sabichi A, Zhang J, et al. Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncol 2023;145:106536.
PMID: 37562095